Unlocking DMT horizons
With Pascal Michael (University of Greenwich), Lisa Luan (Imperial College London), Soma Makai-Bölöni (Center for Human Drug Research) and Carol Routhledge (Small Pharma/Cybin). Moderated by Parker Singleton (Computational Connectomics Lab).
Thursday 19 October, 8PM CET (7PM GMT, 2PM EST, 11AM PST)
Online (OPEN Community Platform)
exploring the clinical potential of DMT
Together, our panel will engage in a dynamic discussion about clinical research with DMT, with attention for the DMT experience and its connection with near-death experiences, regular and prolonged DMT experiences, integration and the clincial relevance of phenomenology. Attendees will have the opportunity to learn about the DMT experience in clinical settings, current status of clinical research, gain a greater understanding of the phenomenology, and explore the future challenges and opportunities.